Table 3 MSA type, titer, and CK level in patients with positive MSA (n = 26)
From: Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups
AGE | SEX | MSA TYPE | Mi-2 titer | NXP-2 titer | MDA-5 titer | TIF1γ titer | SRP titer | CK | |
|---|---|---|---|---|---|---|---|---|---|
1 | 10 | M | MDA5 | 50 | 126 | ||||
2 | 5 | M | MDA5 | 50 | 103 | ||||
3 | 12 | F | MDA5 | 13 | 88 | ||||
4 | 12 | F | MI2 | ≥100 | 14,152 | ||||
5 | 4 | F | MI2 | 97 | 18,992 | ||||
6 | 16 | F | MI2 | 91 | 14,119 | ||||
7 | 4 | F | MI2 | 47 | 3077 | ||||
8 | 5 | F | MI2 | 32 | 1491 | ||||
9 | 2 | F | NXP2 | ≥100 | 475 | ||||
10 | 3 | M | NXP2 | ≥100 | 74 | ||||
11 | 12 | F | NXP2 | ≥100 | 1044 | ||||
12 | 13 | F | NXP2 | ≥100 | 147 | ||||
13 | 8 | F | NXP2 | 52 | 1438 | ||||
14 | 3 | F | NXP2 | 30 | 229 | ||||
15 | 4 | M | NXP2 | 16 | 1040 | ||||
16 | 8 | F | NXP2 | 12 | 4681 | ||||
17 | 10 | F | NXP2 | 11 | 47 | ||||
18 | 12 | F | TIF1γ | 84 | 402 | ||||
19 | 12 | F | PL7 | 13,972 | |||||
20 | 8 | F | SRP | 24 | 132 | ||||
21 | 4 | M | SRP, TIF1γ | 13 | 58 | 93 | |||
22 | 4 | F | NXP2, MDA5 | ≥100 | 34 | 3860 | |||
23 | 5 | F | NXP2, MI2 | 98 | ≥100 | 633 | |||
24 | 3 | F | NXP2, OJ | ≥100 | 1242 | ||||
25 | 3 | M | NXP2, SRP | ≥100 | 12 | 190 | |||
26 | 3 | F | MI2, MDA5 | 16 | 11 | 117 |